Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling

被引:302
作者
Weng, AP
Nam, Y
Wolfe, MS
Pear, WNS
Griffin, JD
Blacklow, SC
Aster, JC
机构
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[5] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Inst Med & Engn,Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/MCB.23.2.655-664.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Constitutive NOTCH signaling in lymphoid progenitors promotes the development of immature T-cell lymphoblastic neoplasms (T-ALLs). Although it is clear that Notch signaling can initiate leukemogenesis, it has not previously been established whether continued NOTCH signaling is required to maintain T-ALL growth. We demonstrate here that the blockade of Notch signaling at two independent steps suppresses the growth and survival of NOTCH1-transformed T-ALL cells. First, inhibitors of presenilin specifically induce growth suppression and apoptosis of a murine T-ALL cell line that requires presenilin-dependent proteolysis of the Notch receptor in order for its intracellular domain to translocate to the nucleus. Second, a 62-amino-acid peptide derived from a NOTCH coactivator, Mastermind-like-1 (MAML1), forms a transcriptionally inert nuclear complex with NOTCH1 and CSL and specifically inhibits the growth of both murine and human NOTCH1-transformed T-ALLs. These studies show that continued growth and survival of NOTCH1-transformed lymphoid cell lines require nuclear access and transcriptional coactivator recruitment by NOTCH1 and identify at least two steps in the Notch signaling pathway as potential targets for chemotherapeutic intervention.
引用
收藏
页码:655 / 664
页数:10
相关论文
共 61 条
[1]   Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[2]   FUNCTIONAL-ANALYSIS OF THE TAN-1 GENE, A HUMAN HOMOLOG OF DROSOPHILA NOTCH [J].
ASTER, J ;
PEAR, W ;
HASSERJIAN, R ;
ERBA, H ;
DAVI, F ;
LUO, B ;
SCOTT, M ;
BALTIMORE, D ;
SKLAR, J .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 :125-136
[3]  
Aster JC, 1997, J BIOL CHEM, V272, P11336
[4]   Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by Notch1 [J].
Aster, JC ;
Xu, LW ;
Karnell, FG ;
Patriub, V ;
Pui, JC ;
Pear, WS .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (20) :7505-7515
[5]   Aspartate mutations in presenilin and γ-secretase inhibitors both impair Notch1 proteolysis and nuclear translocation with relative preservation of Notch1 signaling [J].
Berezovska, O ;
Jack, C ;
McLean, P ;
Aster, JC ;
Hicks, C ;
Xia, WM ;
Wolfe, MS ;
Kimberly, WT ;
Weinmaster, G ;
Selkoe, DJ ;
Hyman, BT .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (02) :583-593
[6]  
Berry LW, 1997, DEVELOPMENT, V124, P925
[7]   A novel proteolytic cleavage involved in Notch signaling:: The role of the disintegrin-metalloprotease TACE [J].
Brou, C ;
Logeat, F ;
Gupta, N ;
Bessia, C ;
LeBail, O ;
Doedens, JR ;
Cumano, A ;
Roux, P ;
Black, RA ;
Israël, A .
MOLECULAR CELL, 2000, 5 (02) :207-216
[8]   Ligand-induced signaling in the absence of furin processing of Notch1 [J].
Bush, G ;
diSibio, G ;
Miyamoto, A ;
Denault, JB ;
Leduc, R ;
Weinmaster, G .
DEVELOPMENTAL BIOLOGY, 2001, 229 (02) :494-502
[9]   Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2 [J].
Capobianco, AJ ;
Zagouras, P ;
Blaumueller, CM ;
ArtavanisTsakonas, S ;
Bishop, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6265-6273
[10]   Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics [J].
Carlesso, N ;
Aster, JC ;
Sklar, J ;
Scadden, DT .
BLOOD, 1999, 93 (03) :838-848